Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

A big thank you to all the members of Congress who signed onto the joint letter to FDA — led by Reps. Norcross, Pocan, and Yoho — asking that the agency withdraw GFI #256 on animal compounding. Here’s the list; read the letter here.

James R. Baird
Jaime Herrera Beutler
Andy Biggs
Dan Bishop
Sanford Bishop
Earl L. Buddy Carter
John R. Carter
Bonnie Watson Coleman
Henry Cuellar
Madeleine Dean
Jefferson Van Drew
Neal P. Dunn, M.D.
Paul A. Gosar, D.D.S.
Mark Green
Jim Hagedorn
Fred Keller
Andy Kim
Debbie Lesko
Zoe Lofgren
Donald Norcross
Ralph Norman
Eleanor Holmes Norton
Mark Pocan
Bill Posey
Denver Riggleman
David P. Roe, M.D.
Michael F.Q. San Nicolas
Kurt Schrader
David Schweikert
Christopher H. Smith
W. Gregory Steube
Van Taylor
Bruce Westerman
Ted S. Yoho, D.V.M.